Plasma cell leukemia
Clinical trials for Plasma cell leukemia explained in plain language.
Never miss a new study
Get alerted when new Plasma cell leukemia trials appear
Sign up with your email to follow new studies for Plasma cell leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New attack plan for rare leukemia: CAR-T cells + stem cell transplant
Disease control OngoingThis study tests a new treatment for a rare and aggressive blood cancer called primary plasma cell leukemia. The approach combines chemotherapy, a stem cell transplant, and two infusions of specially engineered immune cells (CAR-T cells) that target the cancer. The goal is to see…
Matched conditions: PLASMA CELL LEUKEMIA
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug may make stem cell transplants safer for older patients
Disease control OngoingThis early-phase trial tests whether the drug itacitinib can prevent cytokine release syndrome (a severe inflammatory reaction) after a mini stem cell transplant in people aged 60 and older with certain blood cancers. The study also aims to see if itacitinib allows doctors to use…
Matched conditions: PLASMA CELL LEUKEMIA
Phase 1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 26, 2026 18:40 UTC
-
Cancer drug dose study canceled before it began
Knowledge-focused CancelledThis study was designed to find the safest and most effective dose of the chemotherapy drug bendamustine for people with multiple myeloma that had not been cured by earlier treatments. It was a Phase 1 trial, meaning it focused on side effects and dosing, not on curing the diseas…
Matched conditions: PLASMA CELL LEUKEMIA
Phase 1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC